Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury.
Springer Science and Business Media LLC
MetadataShow full item record
Martin, J. L., Gruszczyk, A., Beach, T., Murphy, M., & Saeb-Parsy, K. (2019). Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury.. Pediatr Nephrol, 34 (7), 1167-1174. https://doi.org/10.1007/s00467-018-3984-5
Acute kidney injury (AKI) remains a major problem in critically unwell children and young adults. Ischaemia reperfusion (IR) injury is a major contributor to the development of AKI in a significant proportion of these cases and mitochondria are increasingly recognised as being central to this process through generation of a burst of reactive oxygen species early in reperfusion. Mitochondria have additionally been shown to have key roles in downstream processes including activation of the immune response, immunomodulation, and apoptosis and necrosis. The recognition of the central role of mitochondria in IR injury and an increased understanding of the pathophysiology that undermines these processes has resulted in identification of novel therapeutic targets and potential biomarkers. This review summarises a variety of therapeutic approaches that are currently under exploration and may have potential in ameliorating AKI in children in the future.
Kidney Tubules, Mitochondria, Humans, Reperfusion Injury, Necrosis, Reactive Oxygen Species, DNA, Mitochondrial, Antioxidants, Apoptosis, Oxidative Stress, Acute Kidney Injury, Biomarkers, Mitophagy
Medical Research Council (MR/L017520/1)
Medical Research Council (MC_UU_00015/3)
External DOI: https://doi.org/10.1007/s00467-018-3984-5
This record's URL: https://www.repository.cam.ac.uk/handle/1810/282771
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/